AC
PRAX icon

Allstate Corporation’s Praxis Precision Medicines PRAX Stock Holding History

Allstate Corporation’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$837K Sell
2,500
-1,012
-29% -$320K 0.01% 824
2026
Q1 		$1.13M Buy
+3,512
New +$1.09M 0.01% 763

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Allstate Corporation's PRAX Position: Q2 2026 in Review

Allstate Corporation reduced its Praxis Precision Medicines (PRAX) stake by 29% in Q2 2026, selling an estimated $320K and leaving 2,500 shares worth $837K. The position accounts for 0.01% of the portfolio, ranked #824.

Allstate Corporation first reported a position in PRAX in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.13M in Q1 2026. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Allstate Corporation held 2,500 shares of Praxis Precision Medicines worth $837K as of Q2 2026.
  • Allstate Corporation sold 1,012 Praxis Precision Medicines shares in Q2 2026, an estimated $320K.
  • Praxis Precision Medicines made up 0.01% of Allstate Corporation's portfolio in Q2 2026, its #824 holding.
  • Allstate Corporation first reported a position in Praxis Precision Medicines in Q1 2026 and has held it in 2 quarters since.
  • Allstate Corporation's Praxis Precision Medicines position peaked at $1.13M in Q1 2026.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.